Takeda Pharmaceutical Company Limited (TYO:4502)
4,347.00
-17.00 (-0.39%)
Oct 7, 2025, 12:45 PM JST
TYO:4502 Revenue
Takeda Pharmaceutical Company had revenue of 1.11T JPY in the quarter ending June 30, 2025, a decrease of -8.39%. This brings the company's revenue in the last twelve months to 4.48T, up 1.52% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.
Revenue (ttm)
4,480.25B
Revenue Growth
+1.52%
P/S Ratio
1.52
Revenue / Employee
94.41M
Employees
47,455
Market Cap
6,816.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4,581.55B | 317.79B | 7.45% |
Mar 31, 2024 | 4,263.76B | 236.28B | 5.87% |
Mar 31, 2023 | 4,027.48B | 458.47B | 12.85% |
Mar 31, 2022 | 3,569.01B | 371.19B | 11.61% |
Mar 31, 2021 | 3,197.81B | -93.38B | -2.84% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |
Olympus | 969.02B |
Takeda Pharmaceutical Company News
- 5 days ago - Takeda Pharmaceutical to exit cell therapy research - Reuters
- 5 days ago - Bristol Myers, Takeda to pool data for AI-based drug discovery - Reuters
- 6 days ago - TAK Makes Notable Cross Below Critical Moving Average - Nasdaq
- 11 days ago - Shares of Asian drugmakers drop after Trump threatens tariffs - Reuters
- 12 days ago - Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually - Seeking Alpha
- 13 days ago - 20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries - Business Wire
- 20 days ago - Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran - Business Wire
- 25 days ago - Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit - Business Wire